These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16555327)

  • 1. Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil.
    Callejas Rubio JL; Salmerón Escobar J; González-Calvín J; Ortego Centeno N
    Liver Transpl; 2006 Apr; 12(4):690-1. PubMed ID: 16555327
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation.
    Makisalo H; Koivusalo A; Vakkuri A; Hockerstedt K
    Liver Transpl; 2004 Jul; 10(7):945-50. PubMed ID: 15237383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
    Sağ S; Yeşilbursa D; Güllülü S
    Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation.
    Cadden IS; Greanya ED; Erb SR; Scudamore CH; Yoshida EM
    Ann Hepatol; 2009; 8(2):158-61. PubMed ID: 19502663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension.
    Sahni J
    Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Gordeuk VR
    Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
    Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
    Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

  • 11. Portopulmonary hypertension: short review.
    Stauber RE; Olschewski H
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):385-90. PubMed ID: 19907338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis].
    Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E
    Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435
    [No Abstract]   [Full Text] [Related]  

  • 13. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension.
    Gough MS; White RJ
    Liver Transpl; 2009 Jan; 15(1):30-6. PubMed ID: 19109844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of portopulmonary hypertension with beraprost.
    Kim EJ; Shin MS; Oh KY; Kim MG; Shin KC; Park YM; Kim BR; Chung WJ; Ahn TH; Choi IS; Shin EK
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1503-5. PubMed ID: 21389799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sildenafil in pulmonary hypertension].
    Ewert R; Höper M; Halank M; Winkler J; Wensel R; Opitz C
    Pneumologie; 2003 May; 57(5):291; author reply 291-2; discussion 292. PubMed ID: 12825577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
    Katsuta Y; Zhang XJ; Aramaki T
    Nihon Rinsho; 2001 Jun; 59(6):1186-92. PubMed ID: 11411134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil in older patients with secondary pulmonary hypertension.
    Minotti GC; Corsonello A; Incalzi RA
    J Am Geriatr Soc; 2007 Oct; 55(10):1681-2. PubMed ID: 17908072
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease.
    Montgomery GS; Sagel SD; Taylor AL; Abman SH
    Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New indications for sildenafil in sight. Potency drug is potent in pulmonary hypertension].
    MMW Fortschr Med; 2004 Apr; 146(18):8. PubMed ID: 15366459
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.